ニュース

Search by year or by keyword :

Date	Title
2020-02-13	Amarillo Biosciences to Explore Low-Dose Oral Interferon Therapeutics in China as a Line of Defense Against Coronavirus and Other Viral Indications.
2019-07-29	Amarillo Biosciences and Xiamen Weiyang Pharmaceutical Sign Term Sheet Outlining China Licensing and Royalty Agreement
2018-08-23	Amarillo Biosciences First-Half 2018 Business Update
2017-09-06	Amarillo Biosciences, Inc. Announces Investor Update (Sept 6, 2017)
2015-05-18	Amarillo Biosciences, Inc. Summarizes New Plan of Operation
2015-02-02	Amarillo Biosciences, Inc. Reorganizes, Exits Bankruptcy, and Opens a New Chapter in the Healthcare Industry

アメリカ合衆国:

台湾: